<p>According to the prediction model, each patient was assigned to a low-risk or high-risk group. Significant differences in survival between groups were determined by log-rank analysis. (A) Application of the model to predict the distant metastasis outcomes of TNBC patients. (B) Application of the model to predict the overall survival of TNBC patients.</p
<p>The Kaplan-Meier overall survival curves of two outcome groups classified by MCPHR models using I...
<p>A K-M plot was generated using the miR-4516 + miR-601 + Gleason score + lymph node status model f...
<p>Kaplan-Meier analyses of overall survival according to miR-137 expression in (A) Training set (n ...
<p>A risk score was assigned to each patient as calculated by the prediction model. Based on the ris...
<p>Kaplan-Meier analyses of overall survival (OS), progression-free survival (PFS), distant metastas...
<p>Kaplan-Meier estimates for event-free survival (panel A) and overall survival (panel B) in TNBC p...
<p>MFS is grouped according to Masaoka staging (A), WHO classification (B), extent of resection (C),...
<p>The cohort included 320 GC patients, of whom 151 were alive and 169 were dead. To validate the co...
<p>Kaplan-Meier analyses of overall survival according to miR-137 expression in (A) Training set, TN...
<p>Kaplan-Meier analyses of overall survival (OS), progression-free survival (PFS), distant metastas...
<p>Kaplan-Meier estimates of breast cancer-specific survival in TNM stages III (A) and I & II (B) an...
<p>Survival analysis: Kaplan-Meier curve (log rank test) showed lymph node metastasis was associated...
<p>MFS is grouped according to Masaoka staging (A), WHO classification (B), extent of resection (C),...
<p>Kaplan-Meier estimates of breast cancer-specific survival (A) and recurrence/metastasis-free surv...
<p>A) 92 patients in the training data set. B) 92 patients in the validation data set. C) Risk score...
<p>The Kaplan-Meier overall survival curves of two outcome groups classified by MCPHR models using I...
<p>A K-M plot was generated using the miR-4516 + miR-601 + Gleason score + lymph node status model f...
<p>Kaplan-Meier analyses of overall survival according to miR-137 expression in (A) Training set (n ...
<p>A risk score was assigned to each patient as calculated by the prediction model. Based on the ris...
<p>Kaplan-Meier analyses of overall survival (OS), progression-free survival (PFS), distant metastas...
<p>Kaplan-Meier estimates for event-free survival (panel A) and overall survival (panel B) in TNBC p...
<p>MFS is grouped according to Masaoka staging (A), WHO classification (B), extent of resection (C),...
<p>The cohort included 320 GC patients, of whom 151 were alive and 169 were dead. To validate the co...
<p>Kaplan-Meier analyses of overall survival according to miR-137 expression in (A) Training set, TN...
<p>Kaplan-Meier analyses of overall survival (OS), progression-free survival (PFS), distant metastas...
<p>Kaplan-Meier estimates of breast cancer-specific survival in TNM stages III (A) and I & II (B) an...
<p>Survival analysis: Kaplan-Meier curve (log rank test) showed lymph node metastasis was associated...
<p>MFS is grouped according to Masaoka staging (A), WHO classification (B), extent of resection (C),...
<p>Kaplan-Meier estimates of breast cancer-specific survival (A) and recurrence/metastasis-free surv...
<p>A) 92 patients in the training data set. B) 92 patients in the validation data set. C) Risk score...
<p>The Kaplan-Meier overall survival curves of two outcome groups classified by MCPHR models using I...
<p>A K-M plot was generated using the miR-4516 + miR-601 + Gleason score + lymph node status model f...
<p>Kaplan-Meier analyses of overall survival according to miR-137 expression in (A) Training set (n ...